Target Name: GIMAP8
NCBI ID: G155038
Review Report on GIMAP8 Target / Biomarker Content of Review Report on GIMAP8 Target / Biomarker
GIMAP8
Other Name(s): GTPase, IMAP family member 8 | GTPase IMAP family member 8 | IAN6 | hIAN6 | Immune-associated nucleotide-binding protein 9 | OTTHUMP00000212804 | Protein IanT | IANT | immune-associated nucleotide-binding protein 9 | DKFZp667I133 | GIMA8_HUMAN | IAN-9 | Immune associated nucleotide | Human immune associated nucleotide 6 | human immune associated nucleotide 6 | MGC129545 | IAN9

GIMAP8: Potential Drug Target and Regulator of Cellular Processes

GIMAP8 (GTPase, IMAP family member 8) is a protein that plays a crucial role in various cellular processes. It is a member of the IMAP family, which includes proteins that are involved in intracellular signaling pathways. GIMAP8 is known for its role in regulating the interaction between proteins, including the protein kinase CKL. This protein is also a potential drug target, and various studies have suggested that it may be involved in a variety of diseases, including cancer.

GIMAP8 is a protein that is expressed in many different tissues and cells in the body. It is primarily found in the brain, but can also be found in other organs and tissues, including the heart, liver, and muscle. GIMAP8 is a member of the IMAP family, which includes proteins that are involved in intracellular signaling pathways. This family of proteins is characterized by the presence of a nucleotide-binding oligomerization domain (NBD), which is a structural motif that is involved in protein-protein interactions.

One of the key functions of GIMAP8 is its role in regulating the interaction between proteins, including the protein kinase CKL. CKL is a protein that is involved in intracellular signaling pathways, and is known for its role in the regulation of cell growth and differentiation. GIMAP8 is known to interact with CKL and to regulate its activity. This interaction between GIMAP8 and CKL is important for the regulation of cellular processes, including cell growth, apoptosis, and inflammation.

GIMAP8 is also involved in the regulation of other cellular processes, including cell signaling pathways, cell adhesion, and cell migration. It is known to interact with a variety of other proteins, including the transcription factor NF-kappa-B and the protein T-cell factor-4. These interactions between GIMAP8 and other proteins are important for the regulation of cellular processes and are involved in the development and progression of many diseases.

GIMAP8 is also a potential drug target, and various studies have suggested that it may be involved in a variety of diseases, including cancer. For example, GIMAP8 has been shown to be involved in the regulation of the growth and survival of cancer cells. It is also known to play a role in the regulation of cell cycle progression and the apoptosis of cancer cells. These properties make GIMAP8 a potential target for cancer therapies.

In addition to its potential role in cancer, GIMAP8 is also involved in a variety of other diseases. For example, it is known to be involved in the regulation of the immune response, and is involved in the development and regulation of inflammation. It is also involved in the regulation of the nervous system, and is known to play a role in the development and regulation of neurodegenerative diseases.

GIMAP8 is a protein that plays a crucial role in various cellular processes. It is a member of the IMAP family, and is known for its role in regulating the interaction between proteins, including the protein kinase CKL. GIMAP8 is also a potential drug target and is involved in a variety of diseases, including cancer, neurodegenerative diseases, and immune system disorders. Further research is needed to fully understand the role of GIMAP8 in these diseases and to develop effective therapies.

Protein Name: GTPase, IMAP Family Member 8

Functions: Exerts an anti-apoptotic effect in the immune system and is involved in responses to infections

The "GIMAP8 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GIMAP8 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

GIMD1 | GIN1 | GINM1 | GINS complex | GINS1 | GINS2 | GINS3 | GINS4 | GIP | GIPC1 | GIPC2 | GIPC3 | GIPR | GIT1 | GIT2 | GJA1 | GJA10 | GJA1P1 | GJA3 | GJA4 | GJA5 | GJA8 | GJA9 | GJA9-MYCBP | GJB1 | GJB2 | GJB3 | GJB4 | GJB5 | GJB6 | GJB7 | GJC1 | GJC2 | GJC3 | GJD2 | GJD3 | GJD4 | GK | GK2 | GK3 | GK5 | GKAP1 | GKN1 | GKN2 | GKN3P | GLA | GLB1 | GLB1L | GLB1L2 | GLB1L3 | GLC1C | GLCCI1 | GLCCI1-DT | GLCE | GLDC | GLDN | GLE1 | GLG1 | GLI1 | GLI2 | GLI3 | GLI4 | GLIDR | GLIPR1 | GLIPR1L1 | GLIPR1L2 | GLIPR2 | GLIS1 | GLIS2 | GLIS3 | GLIS3-AS1 | GLMN | GLMP | GLO1 | GLOD4 | GLOD5 | GLP1R | GLP2R | GLRA1 | GLRA2 | GLRA3 | GLRA4 | GLRB | GLRX | GLRX2 | GLRX3 | GLRX3P2 | GLRX5 | GLS | GLS2 | GLT1D1 | GLT6D1 | GLT8D1 | GLT8D2 | GLTP | GLTPD2 | Glucagon-like peptide receptor (GLP-R) | Glucosidase | GLUD1 | GLUD1P2